Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Escitalopram in the Treatment of Patient Suffering From Scizophrenia and Obsessive Compulsive Disorder- an Open Label Study

NCT00456937 is registered in ClinicalTrials.gov with BeerYaakov Mental Health Center as lead sponsor.

NCT NCT00456937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00456937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Escitalopram in the Treatment of Patient Suffering From Scizophrenia and Obsessive Compulsive Disorder- an Open Label Study
Lead sponsor
BeerYaakov Mental Health Center
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2006
Completion date
September 30, 2008
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia